Overview

A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates whether YM443 causes any changes in the electrocardiogram of healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Moxifloxacin
Z 338